Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

1336 – Does Retention in Care Still Correlate With HIV Viral Suppression: Do We Need Different Strategies?

Background “Ending the HIV Epidemic in the US Initiative” strategies include supporting retention and re-engagement in care for people with HIV (PWH) (CDC EHE pillars). As part of a multidisciplinary initiative to enhance retention in care among PWH at our clinic, we hypothesized that we could identify demographic differences between patients who are and are…

1343 – Peer Mobilisation Into Sexual Health Clinics Creates PrEP Demand Among High-Risk Rural Youth in SA

Background Providing oral pre-exposure prophylaxis (PrEP) has not achieved population-level impact in southern Africa due to challenges reaching those with the highest risk of HIV-acquisition.  We hypothesise that peer-led mobilisation into mobile sexual reproductive health (SRH) clinics will promote oral PrEP use amongst adolescents and young adults (AYA) at higher risk of HIV acquisition in…

1342 – Patterns of PrEP Use Among Rural South Africa Youth Given Choice: Process Data From the LAPIS Trial

Background In southern Africa the provision of pre-exposure prophylaxis (PrEP) has not translated into population-level impact due to the challenges of taking a daily oral pill. Injectable PrEP provides an opportunity to overcome this barrier.  Using clinical process data from the Long-Acting PrEP Integrated with Sexual and Reproductive Health (LAPIS) trial, we explore changes in patterns…

1130 – Examining PopART Intervention Impact on HIV in the General Populations of Zambia and South Africa

Background PopART was a cluster randomized trial (CRT) designed to evaluate universal testing and treatment (UTT) strategies for HIV prevention. While CRTs are the gold standard for evaluating population-level effects, they can be subject to selection bias when those enrolled differ from the population of interest. PopART included two intervention arms: (A) combination prevention with…

1340 – Prevalence of Unsuppressed Viral Load: Comparison of 2016-17 and 2022-23 Tanzania HIV Impact Surveys

Background Antiretroviral therapy (ART) improves clinical outcomes of people living with HIV (PLHIV) and achieving viral suppression through ART can prevent HIV transmission. We compared prevalence and correlates of unsuppressed viral load among PLHIV from two Tanzania HIV Impact Surveys (THISs). The first (survey 1 [S1]) was conducted from October 2016-August 2017; the second (survey…

1327 – Heterogeneity of Disengagement From Antiretroviral Care Matters for Treatment Success

Background Disengagement from antiretroviral treatment undermines HIV programme success. Current approaches targeting interventions at specific demographic groups miss most people out of care. Classifying patterns of engagement could use precision public health principles to identify unique care needs, and inform service development targeted at patients with similar experiences. Methods Using routine health data from the…

1328 – Patterns of Engagement After Restarting Antiretroviral Treatment in South Africa

Background As cycling in and out of HIV care over time becomes the norm for people with HIV, most commencing antiretroviral therapy are now restarting rather than initiating treatment for the first time. Understanding patterns of engagement after a substantial treatment interruption could help to direct service implementation and choice of interventions for this crucial…

1346 – Impact of CAB-LA Versus Oral PrEP in Reducing HIV Incidence Among MSM in Thailand: A Modelling Study

Background Long acting preexposure prophylaxis (PrEP) can address periods of partial adherence among individuals using oral PrEP. Using PrEP dispensing records, we determined the proportion of partially adherent men-who-have-sex-with-men (MSM) in Thailand who return within ten weeks and could benefit from cabotegravir as long-acting PrEP (CAB-LA). We then used a mathematical HIV transmission model to…

1251 – Irregular Menstruation Among Women Is Associated With COVID-19 Infection, but Not Vaccination

Background Women reported increased incidence of irregular menstruation (IM) during the COVID-19 (COVID) pandemic. No research has evaluated IM among women living with HIV (WWH) during the COVID pandemic, which is key to understanding reproductive health during co-infections. Methods From 2021-2023, cross-sectional data were collected from the Study of Treatment and Reproductive Outcomes (STAR) cohort…

1283 – Topical Doxycycline Inserts Show High Efficacy Against Vaginal Chlamydia Acquisition in Macaques

Background Bacterial STIs are on the rise globally. Fast-dissolving dual-compartment (vaginal/rectal) inserts containing doxycycline (DOX) provide an alternate approach to STI prevention that can maximize local DOX concentrations while minimizing systemic distribution.   Here, we performed preclinical studies to evaluate the pharmacokinetics (PK) and protective efficacy following vaginal administration of CONRAD-developed inserts containing DOX against vaginal C.…